Partner Therapeutics' BIZENGRI receives FDA Commissioner's National Priority Voucher for NRG1 fusion-positive cholangiocarcinoma

Diakonos Oncology's DOC1021 granted US FDA Fast Track Designation for unresectable or metastatic cutaneous melanoma

Racura Oncology identifies mechanism of action for (E,E)-bisantrene

Bayer to acquire Perfuse Therapeutics in USD2.45bn deal to expand ophthalmology pipeline

NextCell Pharma and FUJIFILM Biosciences launch global MSC research product

ZYUS Life Sciences receives second US pain management patent

MingMed Biotechnology presents QA102 Phase II trial data in intermediate AMD at ARVO 2026

Alebund Pharmaceuticals completes AP301 Phase III clinical trial patient enrolment for hyperphosphataemia

Vanda Pharmaceuticals NEREUS (tradipitant) commercially available for Motion sickness in US

Spinogenix to present tazbentetol preclinical results in glaucoma and diabetic retinopathy models at ARVO 2026

Specialised Therapeutics' chronic graft-versus-host disease therapy approved in Australia

Telix Pharmaceuticals' MAA for TLX101-Px (Pixlumi) accepted for European review

Bambusa Therapeutics completes patient enrolment in Phase 1b/2a trial for atopic dermatitis

Lab Thread launches unified digital platform for biological research workflows

Curocell secures full approval for RIMQARTO to enter CAR-T therapy market